跳至主要内容
临床试验/NCT03247413
NCT03247413终止4 期

Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2019年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
63
试验地点
1
主要终点
Number of Lesions With Post-Ablation Neuritis

研究概览

简要总结

Chronic neck and back pain has become one of the leading causes of disability and loss of productivity. For many patients with facet or sacroiliac joint mediated pain who have responded to diagnostic nerve blocks, radiofrequency ablation of the nerves innervating the joints can provide long term relief. Radiofrequency ablation (RFA) is a relatively safe procedure with minimal risk of adverse events. However, with any procedure involving damage to the peripheral nervous system, there is risk of post-procedure neuropathic pain. The investigators will test the hypothesis that dexamethasone injection delivered at the time of lesion effectively prevents the development of post-ablation neuritis through a placebo-controlled, double-blind, randomized trial in patients undergoing cervical, thoracic, lumbar, and sacroiliac joint radiofrequency denervations

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The patient, care providers, and principle investigator will be blinded.

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a diagnosis of either cervical, thoracic, or lumbar facet or sacroiliac joint pain who have responded to medial branch blocks and are already scheduled for bilateral radiofrequency ablations
  • age greater than 18 years old
  • English speaking

排除标准

  • patient not previously scheduled for radiofrequency ablation of the cervical, thoracic, or lumbar facets, or sacroiliac joints
  • on anticoagulation
  • have a pacemaker
  • age less than 18 years old
  • non-English speaking

研究组 & 干预措施

Dexamethasone

Experimental

Lesions where dexamethasone 4 milligram is administered post-radiofrequency ablation

干预措施: Dexamethasone 4 mg/ml (Drug)

Placebo

Placebo Comparator

Lesions where 1 milliliter of normal saline is administered post-radiofrequency ablation

干预措施: Normal saline (Drug)

结局指标

主要结局

Number of Lesions With Post-Ablation Neuritis

时间窗: 4 weeks

Each patient had 2 lesions. One Lesion was treated with dexamethasone. The other lesion was treated with placebo. We then looked at the number of lesions that developed post-ablation neuritis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验